SELNET Associated Partners are considered expert centers in sarcoma from the countries that are part of SELNET project. The main objective of the Associates Centers is to participate in an observational study and translational research program. They also receive assistance of complex clinical cases peer-review shared within the Consortium.

List of SELNET Associated Partners:

  • Canarian Universitary Hospital (Spain) 
  • Sant Pau Hospital (Spain)
  • San Carlos Clinical Hospital of Madrid (Spain
  • Son Espases Universitary Hospital (Spain)  
  • Basurto Universitary Hospital (Spain)
  • Vall d’Hebron Hospital (Spain)  
  • Bergonié Institute (France)
  • Gustave Roussy Center (France)
  • Instituto Mexicano del Seguro Social Hospital de Oncología del Centro Médico Nacional Siglo XXI (México)
  • National Institute of Pediatrics (México)
  • Naval Hospital (México)
  • University Center Against Cancer, UANL, Monterrey (México)
  • 20 November Hospital, ISSSTE (México)
  • National Cancer Institute of Brazil (INCA) (Brazil)
  • Barretos Cancer Hospital (Brazil
  • ABC Faculty of Medicine (Brazil
  • Amaral Carvalho Hospital (Brazil)
  • Sírio-Libanês Hospital (Brazil) 
  • Regional Integration Oncology Center Foundation / COIR (Argentina)
  • Escuela de agudos Dr. Ramón Madariaga Hospital (Argentina)
  • Rafael Ángel Calderón Guardia Hospital (Costa Rica)
  • San Paul Hospital (Costa Rica) 
  • México Hospital (Costa Rica)
  • San Juan de Dios Hospital (Costa Rica)
  • Max Peralta Hospital (Costa Rica)
  • IREN North (Perú) 
  • Clínica Universidad de los Andes (Chile)
  • Hospital Clínico Universidad de Chile (Chile)
  • Centro de Cáncer, Clínica San Carlos de Apoquindo (Chile)
  • Instituto Oncologico Oriente Boliviano (Bolivia)
  • Fundacion Hospitalaria San Vicente de Paul (Colombia)
  • Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid (Panamá)

Established in Montecaseros 1020, M5500 Mendoza, Argentina

The COIR Foundation is a non-profit institution dedicated to improving the quality of life of cancer patients and their families through excellent treatment and a comprehensive support service, regional in scope in the west of the country.


  • Gema Aguil, Oncologist, PI
  • Julio Banffi, PhD, SC
  • Viviana Leiva, Oncologist, SI
  • Patricia Furlan, SC

It is located in Paseo Dr. Begiristain 121, San Sebastian 20014, Spain.

Osakidetza is the Basque Country Public Health System, in Spain. The Basque Autonomous Community consists of three different provinces, known as Alava, Bizcaia, and Gipuzkoa.

Gipuzkoa Clinical Oncology Management Unit, located in San Sebastian, is the center that provides public cancer assistance to Gipuzkoa province. The hospital is specialized in diagnosis, treatment, and research of different types of cancer, with a long experience in multidisciplinary tumor boards.

Staff  Members:

  • Ana Paisán Ruiz, Medical Oncologist and Partner Leader
  • Josep Manuel Pep Piera, Medical Oncologist
  • Manuel Moreno Valladares, Pathologist
  • María Aranzazu Juaristi Abaunz, Pathologist
  • María Hidalgo Ordoqui, Clinical Trials Coordinator
  • María Diez Zubizarreta, Clinical Trials Coordinator

Established in Passeig de la Vall d’Hebron, 119, 08035 Barcelona (Spain)

Vall d’Hebron University Hospital is the largest hospital complex in Catalonia and one of the most important in Spain. It offers highly complex healthcare through the public, teaching and community hospital. At its facilities, work on research, teaching and innovaton is carried out. The Vall d’Hebron Oncology Institute (VHIO) unites the efforts of multidisciplinary professionals with skills ranging from preclinical research to translational and clinical research.


  • Claudia Valverde, Oncologist, PI
  • Adriana Rojo, Project Manager

Establish in Calle del Prof Martín Lagos, s/n, 28040 Madrid (Spain)

Hospital Universitario Clínico San Carlos is a public and teaching academic institution, with almost 1000 beds. Our hospital is one of the National Reference Centres in sarcoma in Spain (CSUR).

Dr Juan Luis Cebrian Parra, from our Orthopedic and Traumatological Surgery Department, is in charge of our Sarcoma Multidisciplinary Team (MDT) and responsible for its functioning and planning.  All the members of the MDTs work hard to provide high-standard healthcare for the patients, optimizing treatments, new therapies and surgical techniques.

Our institution actively participates in clinical trials from phase I to phase IV in sarcomas to provide our patients with cutting-edge, high-quality treatments. The department of Medical Oncology counts with a well-organized clinical trial Unit. In addition to SELNET, our Unit is part of EORTC and GEIS, actively participating in academic clinical trials from these cooperative groups.

For additional information, please visit the site:


  • Dr Antonio Casado Herráez (Medical Oncologist), PI
  • Dr Aranzazu Manzano Fernández (Medical Oncologist), coinvestigator
  • Gloria Marquina Ospina (Medical Oncologist), coinvestigator
  • Dr Luis Ortega Medina (Head of the Department of Pathology), reference pathologist
  • Ana Paula Leyva: Sarcoma Case Manager Nurse
  • Helena Olivera Pérez-Frade and Raquel Rodriguez Damiano (Study coordinators)
  • Head of Clinical trials coordination Unit: Dr Rosario Alfonso San Segundo

Established in José Manuel Infante 805, Providencia, Región Metropolitana, Chile

Fundación Arturo Perez López (FALP) started its activity in August 1955.

In 1960, FALP became the first hospital in Chile with a tumor board and surgical oncologist.

FALP has progressively increased its activity through time, with more than 642,000 outpatient visits, more than 86,000 new patients, more than 242,000 chemotherapy courses, 55,000 oncological patients, 36,000 surgeries, 134,000 monographies performed in the screening program, 74,000 radiotherapy sessions and 43,000 hospital admissions in the period 2011-2017.

FALP is not only focused on cancer therapy, but also in medical education and screening programs for early cancer detection, committed to reach all the patients.


  • Dr. Luis Matamala Rebolledo (Medical Oncologist), PI
  • Dr. María Magdalena Delgado (Medical Oncologist), SI
  • Dr. Christian Caglevic Medina (Medical Oncologist), SI
  • Dr. Nicolas Devaud Jaureguiberry (Medical Oncologist) SI
  • Katherine Hermosilla, SC
  • Cyntia Obreque, SC

Established in Avenida Edgardo Rebagliati 490, Jesus Maria 15072, Lima (Peru)

VAT Number : PE20131257750

The Hospital Edgardo Rebagliati Martins is the largest, teaching and the most important institution that belongs to the Social security in Peru. It was founded on November 3, 1958.  Currently, there is a high level of specialization with 93 specialized medical services, 1600 beds, and 115 outpatient services.

Also, there are nearly 1100 skilled physicians who manage complex diseases, being the most prevalent, the oncological diseases. Currently, the hospital is one of the most modern and complex institutions in the country, and is also one of the National reference centers in Sarcomas in Peru.

Principal Investigator:

  • Paul Adriazola Vicente, Oncological Surgeon (PI)


  • Denisse Castro Uriol, Medical Oncologist
  • Luis Sialer Vildozola, Oncological orthopedic surgeon
  • Yan Carlos Vargas Caycho- Radiotherapist
  • María del Pilar Quiñones Ávila, Pathologist
  • Iván Maza Medina, Pediatric Oncologist

Study Coordinators:

  • Denisse Castro Uriol, Medical Oncologist
  • Luis Sialer Vildozola, Oncological orthopedic surgeon
  • Yan Carlos Vargas Caycho- Radiotherapist

Instituto Nacional del Cancer (INCAN)                                                                                       

Established in  Ruta 2 km 24 ramal Areguá. Capiatá, Paraguay

The Institute was founded in 1985 as the Instituto Nacional del Cancer y del Quemado, which as its name implies, included burn patients as well as cancer patients. In 1998, the Burn Unit was separated from the Cancer Unit,  which at the time included the Hospital named “Prof. Dr. Manuel Riveros” and the Clinic “María y Josefa Barbero”. In 2016, the Clinic was officially separated from INCAN.

Until the date, the INCAN includes the Hospital “ Prof. Dr. Manuel Riveros”  and the PRONAC (National Cancer Control Program).

INCAN is the national reference center for cancer patients and its main goal is to ensure the best cancer care possible. It comprises adequate prevention programs, the conformation of  multidisciplinary teams for correct diagnosis, optimal treatment, rehabilitation and palliative medicine.

Principal Investigator:

  • Dra Gonzalez Donna, Maria Lucila (Oncology)


  • Dra Cinthia Gauna (Oncology)
  • Dra Maria Luisa Cabañas (Pathology)
  • Dr Enrique Ayala (Pathology)
  • Dr Lester Flores (Oncology)
  • Dr Miguel Aguero (Oncology)
  • Dra Nadia Roca (Images)
  • Dr Bladismir Vega (Surgery)
  • Dr William Villalba (Surgery)

Study Coordinators:

  • Dra Lilian Gimenez (Pathology)
  • Dra Laura Rojas (Pathology)

Founded in Basel, Switzerland
The SwissSarcomaNetwork is a society that aims to foster the interinstitutional and transdisciplinary work-up, treatment and follow-up care of all patients with sarcomas by concentration of competence, education and research as well as resources. The main objective is to define, improve and ensure quality of care and patient outcome.
The SSN society organizes the SwissSarcomaBoard and maintains a data registry, through which patient outcome is assessed by indicators of quality, to improve transparency both for patients and legal body/health care authorities, and to organize research projects and collaborations with international partners such as the SELNET Project. Education is provided through monthly webinars and forum exchange (

  • Prof. Bruno Fuchs, MD PhD (Reference Orthopedic Oncologist), Principal Investigator
  • Prof. Beata Bode, MD (Reference Pathology), Sub-Investigator
  • Larissa Slater (Administrative Assistant), Study Coordinator

Is a public hospital entirely dedicated to the treatment of cancer, center of reference for the public system in oncology and radiotherapy. We are part of the unit of diagnosis and treatment of musculoskeletal tumors of the province that works in a multidisciplinary and multi-institutional way.


  • Gisela German, medical oncologist. PI
  • Agustina Tissera, senior fellow in medical oncology. SI
  • Pablo Segura, oncology orthopedist. SI
  • Florencio Segura, oncology orthopedist. SI

Hospital Universitario Austral is a nonprofit organization known for its medical and nursing specialization, the quality of care, its highly specialized tertiary care, its infrastructure and state-of-the-art technology. Its physicians and nurses provide quality human, technical and scientific services to patients, helping them to preserve, recover or maintain their health. This can only be achieved with a structured continuing education plan, where every individual practitioner strives to help patients recover as fast as possible. Therefore, patients and staff are required to follow physicians’ indications regularly working hand in hand with nurses.

In June 2013 Hospital Universitario Austral gained the highest accreditation standard granted worldwide to healthcare centers by Joint Commission International (JCI). This positioned Hospital Universitario Austral among the first hospitals worldwide to achieve the Academic Medical Center Hospital certification. The accreditation process involved a deep cultural change of processes, policies and quality standards audited against the most rigorous international benchmarks. Again accredited in 2016 and 2019.


  • Marcos Galli Serra. PI
  • Dr. Rizzo. SI
  • Miguel Mnaglio. SI
  • Carlos Silva. SI
  • Manuel de Elías. SI
  • Walter Parizzia. SI
  • Nicolás Marcolini. SI
  • Luis Daverede. SI

The hospital is located on José de Fábrega Avenue in Panama City, Panama.

Complejo Hospitalario Metropolitano Dr. Arnulfo Arias Madrid, founded on May 26, 1962 is the largest and most specialized public medical facility of the Social Security Fund (CSS) in Panama City and constitutes the most important reference center. The hospital has a vast medical body, which attends to a portfolio of health services that together maintain more than 70 different specialties and subspecialties. It has 942 beds and a human team that amounts to some 5,000 collaborators, including 800 medical specialists and subspecialists; 895 nurses, technicians and other health personnel that provide specialized medical services for the national population.

Principal Investigator: Marina Pacheco, Pathologist

Sub-Investigators Alan Ríos, orthopaedic oncology